144 related articles for article (PubMed ID: 32042775)
1. Prognostic implications of human papillomavirus type 16 status in non-oropharyngeal head and neck cancer: a propensity score matching analysis.
Zhu Y; Xia X; Gao L; Zhu X; Diao W; Liang Z; Gao Z; Chen X
Ann Transl Med; 2019 Dec; 7(23):759. PubMed ID: 32042775
[TBL] [Abstract][Full Text] [Related]
2. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
4. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
[TBL] [Abstract][Full Text] [Related]
7. HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients.
Burr AR; Harari PM; Ko HC; Chen S; Yu M; Baschnagel AM; Kimple RJ; Witek ME
Otorhinolaryngol Head Neck Surg; 2018; 3(1):. PubMed ID: 30271885
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
9. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy in Metastatic Oropharyngeal Cancer.
Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
12. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
[TBL] [Abstract][Full Text] [Related]
13. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Khwaja SS; Baker C; Haynes W; Spencer CR; Gay H; Thorstad W; Adkins DR; Nussenbaum B; Chernock RD; Lewis JS; Wang X
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1132-41. PubMed ID: 27209503
[TBL] [Abstract][Full Text] [Related]
14. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes in Human Papillomavirus-Associated Nonoropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-analysis.
Sahovaler A; Kim MH; Mendez A; Palma D; Fung K; Yoo J; Nichols AC; MacNeil SD
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1158-1166. PubMed ID: 33057610
[TBL] [Abstract][Full Text] [Related]
16. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
